HLA-DRB1 Polymorphisms and Rheumatologic Manifestations in Chronic Hepatitis C
Natália Bronzatto Medolago1, Adriana Camargo Ferrasi1, Oswaldo Melo da Rocha1
1Department of Internal Medicine, Botucatu Medical School, Sao Paulo State University, Botucatu, Brazil.
Insights
Human Leukocyte Antigen (HLA) polymorphisms were investigated for associations with rheumatologic manifestations (RM) in chronic hepatitis C patients. The study found no susceptibility association between HLA-DRB1 alleles and RM, suggesting distinct pathways for HCV-related RM and diffuse connective tissue disease-related RM.
Area of Science:
- Immunogenetics
- Hepatology
- Rheumatology
Background:
- Hepatitis C virus (HCV) infection is linked to rheumatologic manifestations (RM), often mimicking diffuse connective tissue diseases (DCTD).
- Distinguishing HCV-related RM from DCTD-related RM is clinically challenging.
- Host genetic factors, including Human Leukocyte Antigen (HLA) polymorphisms, are implicated in HCV infection, but their role in differentiating RM types is unclear.
Purpose of the Study:
- To investigate associations between HLA-DRB1 alleles and rheumatologic manifestations in patients with chronic hepatitis C.
- To determine if HLA-DRB1 polymorphisms can help differentiate between HCV-related RM and DCTD-related RM.
Main Methods:
- 152 patients with chronic hepatitis C underwent rheumatologic examination.
- HLA-DRB1 typing was performed using Polymerase Chain Reaction-Sequence Specific Oligonucleotides (PCR-SSO).
Main Results:
- 73% of patients exhibited rheumatologic complaints not attributable to other causes.
- The DRB1*08 allele appeared to offer protection against RM in chronic hepatitis C.
- No significant susceptibility association was found between HLA-DRB1 alleles and RM.
Conclusions:
- The lack of association between HLA-DRB1 and the studied RM suggests distinct pathophysiological mechanisms.
- HCV-related RM and DCTD-related RM likely involve different biological pathways.
Background/Aims:
Hepatitis C has been associated with rheumatologic manifestations (HCV-related RM). Clinically, HCV-related RM may be indistinguishable from the symptoms that occur in diffuse connective tissue diseases (DCTD-related RM), making the differential diagnosis difficult. Host genetic factors, such as the Human Leukocyte Antigens (HLA) polymorphisms were associated with HCV infection, however, there are no studies that discriminate between HCVrelated RM and DCTD-related RM. This study focused on verifying associations between HLADRB1 and RM in patients with chronic hepatitis C, aiming to distinguish between DCTD-related RM and HCV-related RM.
Methods:
The participants were 152 individuals, of both sexes, aged between 18 and 80 years, and affected by chronic hepatitis C. The patients underwent rheumatologic physical examination and HLA-class II (HLA-DRB1) typing was performed by PCR-SSO (Polymerase Chain Reactionsequence Specific Oligonucleotides).
Results:
A significant number of patients with rheumatologic complaints (73%) not attributed to other causes was observed. DRB1*08 allele seems to confer protection against RM in chronic hepatitis C. There is no susceptibility association between HLA-DRB1 alleles and RM.
Conclusion:
The absence of association between HLA-DRB1 and the rheumatologic manifestations studied suggests that the pathophysiological pathways of DCTD-related RM and HCV-related RM are distinct.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Rh Blood Group
Chronic Kidney Disease II: Clinical Manifestations


